Prevacid

Adult Dosing .

Dosage forms:  DR CAP: 30 mg

Dosage Forms Discontinued in US

[15 mg DR cap not avail. as brand; see generic]

GERD

[non-erosive, symptomatic]

Dose: 15 mg PO/NG qd x8wk; Info: give before meals; may open cap, see PPI Administration Alternatives table

[erosive esophagitis, short-term tx]

Dose: 30 mg PO/NG qd x8-16wk; Info: give before meals; may open cap, see PPI Administration Alternatives table

[erosive esophagitis, maintenance tx]

Dose: 15 mg PO/NG qd; Info: give before meals; may open cap, see PPI Administration Alternatives table

duodenal ulcer

[15 mg PO/NG qd-bid x4-8wk]

Info: maint. dose 15 mg/day; give before meals; may open cap, see PPI Administration Alternatives table

gastric ulcer

[30 mg PO/NG qd-bid x8wk]

Info: maint. dose 15-30 mg/day; give before meals; may open cap, see PPI Administration Alternatives table

gastric ulcer prophylaxis, NSAID-assoc.

[15-30 mg PO/NG qd]

Info: give before meals; may open cap, see PPI Administration Alternatives table

hypersecretory conditions

[individualize dose PO/NG qd-bid]

Start: 60 mg PO/NG qd; Info: doses up to 90 mg PO bid have been used; divide doses >120 mg/day; give before meals; may open cap, see PPI Administration Alternatives table

H. pylori infection

[30-60 mg PO bid x14 days]

Info: part of multi-drug regimen, dosing may vary; give before meals; may open cap; see PPI Administration Alternatives table; search 'H. pylori Tx' for epocrates H. pylori Tx Regimens decision tool

renal dosing

[no adjustment]

renal impairment: no adjustment

HD/PD: no adjustment; no supplement

hepatic dosing

[adjust dose amount]

Child-Pugh Class C: 15 mg qd

Peds Dosing .

Dosage forms:  DR CAP: 30 mg

Dosage Forms Discontinued in US

[15 mg DR cap not avail. as brand; see generic]

GERD, non-erosive symptomatic

[1-11 yo, <30 kg]

Dose: 15 mg PO/NG qd x12wk; Max: 30 mg bid; Info: may incr. dose after 2wk; give before meals; may open cap, see PPI Administration Alternatives table

[1-11 yo, >30 kg]

Dose: 30 mg PO/NG qd x12wk; Max: 30 mg bid; Info: may incr. dose after 2wk; give before meals; may open cap, see PPI Administration Alternatives table

[12-17 yo]

Dose: 15 mg PO/NG qd x8wk; Max: 30 mg bid; Info: may incr. dose after 2wk; give before meals; may open cap, see PPI Administration Alternatives table

GERD, erosive esophagitis

[1-11 yo, <30 kg]

Dose: 15 mg PO/NG qd x12wk; Max: 30 mg bid; Info: may incr. dose after 2wk; give before meals; may open cap, see PPI Administration Alternatives table

[1-11 yo, >30 kg]

Dose: 30 mg PO/NG qd for x12wk; Max: 30 mg bid; Info: may incr. dose after 2wk; give before meals; may open cap, see PPI Administration Alternatives table

[12-17 yo]

Dose: 30 mg PO/NG qd x8wk; Max: 30 mg bid; Info: may incr. dose after 2wk; give before meals; may open cap, see PPI Administration Alternatives table

H. pylori infection (off-label)

[15-24 kg]

Dose: 30 mg PO bid x10-14 days; Info: part of multi-drug regimen; give >15min before meals; may open cap, see PPI Administration Alternatives table; search 'H. pylori Tx' for epocrates H. pylori Tx Regimens decision tool

[25-34 kg]

Dose: 45 mg PO bid x10-14 days; Info: part of multi-drug regimen; give >15min before meals; may open cap, see PPI Administration Alternatives table; search 'H. pylori Tx' for epocrates H. pylori Tx Regimens decision tool

[>35 kg]

Dose: 60 mg PO bid x10-14 days; Info: part of multi-drug regimen; give >15min before meals; may open cap, see PPI Administration Alternatives table; search 'H. pylori Tx' for epocrates H. pylori Tx Regimens decision tool

renal dosing

[no adjustment]

renal impairment: no adjustment

HD/PD: no adjustment; no supplement

hepatic dosing

[adjust dose amount]

Child-Pugh Class C: 15 mg qd